Lawson Eng1,2,3, Xin Qiu4, Jie Su4, Dan Pringle2, Chongya Niu1,2, Mary Mahler2, Rebecca Charow2, Jodie Villeneuve2, Oleksandr Halytskyy2, Christine Lam2, Kyoko Tiessen2, M Catherine Brown2, Doris Howell1,2, Meredith E Giuliani2,5, Jennifer M Jones2, Shabbir M H Alibhai3, David P Goldstein6, Wei Xu4,7, Peter Selby8,9,10, Geoffrey Liu1,2,3,7. 1. Division of Medical Oncology and Hematology, Department of Medicine, Princess Margaret Cancer Centre/University Health Network and University of Toronto, Toronto, Ontario, Canada. 2. Ontario Cancer Institute, Toronto, Ontario, Canada. 3. Department of Medicine, University Health Network, Toronto, Ontario, Canada. 4. Department of Biostatistics, Princess Margaret Cancer Centre/University Health Network and University of Toronto, Toronto, Ontario, Canada. 5. Department of Radiation Oncology, Princess Margaret Cancer Centre, Toronto, Ontario, Canada. 6. Department of Otolaryngology-Head and Neck Surgery, University of Toronto, University Health Network, Toronto, Ontario, Canada. 7. Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 8. Centre for Addiction and Mental Health, University of Toronto, Toronto, Ontario, Canada. 9. Department of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada. 10. Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
Abstract
BACKGROUND: Second-hand smoke (SHS) is a significant barrier to smoking cessation after a diagnosis of cancer in patients with lung as well as head and neck cancers. In the current study, the authors evaluated the effect of SHS on smoking cessation among patients with those cancers not traditionally perceived to be strongly associated with smoking. METHODS: Patients recruited from a single tertiary care center completed a self-administered questionnaire. Multivariate logistic regression and Cox proportional hazards models evaluated the association of sociodemographics, clinicopathological variables, and exposure to SHS with either smoking cessation or time to quitting. RESULTS: In all, 926 patients with diverse cancer subtypes completed the questionnaire. Of the 161 who were current smokers at the time of their cancer diagnosis, 48% quit after diagnosis. Lack of exposure to SHS at home was found to be associated with smoking cessation at any time after diagnosis (adjusted odd ratio, 4.28; 95% confidence interval, 1.56-11.78 [P =.005]), with similar trends noted 1 year after diagnosis (adjusted odds ratio, 2.56; 95% confidence interval, 0.91-7.22 [P =.08]). There was a significant inverse dose-response relationship between hours of SHS exposure at home and smoking cessation. Spousal and peer smoking were not found to be significantly associated with smoking cessation on multivariate analysis (P>.05). Kaplan-Meier analysis found that of patients who did quit smoking, 61% quit within 6 months of their cancer diagnosis. CONCLUSIONS: Exposure to SHS at home is a significant barrier to smoking cessation in patients whose cancers are not traditionally perceived as being related to tobacco. SHS should be a key consideration in the development of survivorship programs geared toward smoking cessation for all patients with cancer.
BACKGROUND: Second-hand smoke (SHS) is a significant barrier to smoking cessation after a diagnosis of cancer in patients with lung as well as head and neck cancers. In the current study, the authors evaluated the effect of SHS on smoking cessation among patients with those cancers not traditionally perceived to be strongly associated with smoking. METHODS:Patients recruited from a single tertiary care center completed a self-administered questionnaire. Multivariate logistic regression and Cox proportional hazards models evaluated the association of sociodemographics, clinicopathological variables, and exposure to SHS with either smoking cessation or time to quitting. RESULTS: In all, 926 patients with diverse cancer subtypes completed the questionnaire. Of the 161 who were current smokers at the time of their cancer diagnosis, 48% quit after diagnosis. Lack of exposure to SHS at home was found to be associated with smoking cessation at any time after diagnosis (adjusted odd ratio, 4.28; 95% confidence interval, 1.56-11.78 [P =.005]), with similar trends noted 1 year after diagnosis (adjusted odds ratio, 2.56; 95% confidence interval, 0.91-7.22 [P =.08]). There was a significant inverse dose-response relationship between hours of SHS exposure at home and smoking cessation. Spousal and peer smoking were not found to be significantly associated with smoking cessation on multivariate analysis (P>.05). Kaplan-Meier analysis found that of patients who did quit smoking, 61% quit within 6 months of their cancer diagnosis. CONCLUSIONS: Exposure to SHS at home is a significant barrier to smoking cessation in patients whose cancers are not traditionally perceived as being related to tobacco. SHS should be a key consideration in the development of survivorship programs geared toward smoking cessation for all patients with cancer.
Authors: Devon Alton; Lawson Eng; Lin Lu; Yuyao Song; Jie Su; Delaram Farzanfar; Rahul Mohan; Olivia Krys; Katie Mattina; Christopher Harper; Sophia Liu; Tom Yoannidis; Robin Milne; M Catherine Brown; Ashlee Vennettilli; Andrew J Hope; Doris Howell; Jennifer M Jones; Peter Selby; Wei Xu; David P Goldstein; Geoffrey Liu; Meredith E Giuliani Journal: J Oncol Pract Date: 2018-04-20 Impact factor: 3.840
Authors: Oladimeji Akinboro; Odunayo Olorunfemi; Prasanta Basak; Elizabeth Phillips; Daniel Pomerantz; Bernard Bernhardt; Rasim Gucalp; Stephen Jesmajian; Jamie S Ostroff Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-06-22 Impact factor: 4.254
Authors: Arthur L Brody; Todd Zorick; Robert Hubert; Gerhard S Hellemann; Shabnam Balali; Sarah S Kawasaki; Lizette Y Garcia; Ryutaro Enoki; Paul Abraham; Paulina Young; Charles McCreary Journal: Nicotine Tob Res Date: 2016-08-03 Impact factor: 4.244